| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 11 Feb 2025 | 3 Feb 2025 |
| Windlas Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2025 inter alia to consider and approve To inter alia consider and approve the un-audited standalone and consolidated financial results for the quarter and nine months ended December 31 2024 Outcome of the Board Meeting held on February 11, 2025 Outcome of the Board Meeting Re-appointment of Mr. Hitesh Windlass as Managing Director and Mr. Manoj Kumar Windlass as Joint Managing Director (As Per BSE Announcement Dated on: 11/02/2025) | ||
| Board Meeting | 12 Nov 2024 | 5 Nov 2024 |
| Windlas Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to consider and approve Intimation for the Board Meeting scheduled to be held on Tuesday November 12 2024 Approval of unaudited financial results for the quarter and half year ended 30th September, 202 (As Per BSE Announcement Dated on 12.11.2024) | ||
| Board Meeting | 13 Aug 2024 | 2 Aug 2024 |
| Windlas Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve A meeting of the Board of Directors of the Company is scheduled to be held on Tuesday August 13 2024 inter alia to consider and approve the un-audited standalone and consolidated financial results for the quarter ended June 30 2024. approval of the Un-audited Standalone and Consolidated Financial Results for the Quarter ended June 30, 2024. Approval of un-audited standalone and consolidated financial results for the quarter ended June 30, 2024 (As Per BSE Announcement Dated on 13.08.2024) | ||
| Board Meeting | 20 May 2024 | 10 May 2024 |
| Windlas Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2024 inter alia to consider and approve approve the audited standalone and consolidated financial results for the quarter and year ended March 31 2024 and to consider recommendation of dividend if any amongst other routine matters. Outcome of the Board Meeting Re-appointment of Mr. Pawan Kumar Sharma as an Executive Director (As Per BSE Announcement Dated on 20/05/2024 | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
